Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Furen Huaiqingtang Pharmaceuticals is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Furen Pharmaceutical Group. Established in 2002 and headquartered in Wuzhi County, Henan Province, the company specializes in the production of small-volume injections and lyophilized powder injections. Its extensive product portfolio includes a range of generic Western medicines and Traditional Chinese Medicine (TCM) extracts, targeting therapeutic areas such as antiviral, cardiovascular, and metabolic health. Key commercial products include ribavirin, betahistine hydrochloride, and coenzyme A. The company operates modern, GMP-certified facilities with significant production capacity, serving both domestic and international markets. Despite financial challenges faced by its parent group, Huaiqingtang remains an active entity in the manufacturing of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Furen Huaiqingtang Pharmaceuticals.